In several European countries discontinued the use of hydroxychloroquine in the treatment COVID-19

France, Italy and Belgium have taken measures to eliminate the use of protivokrazhnogo of hydroxychloroquine for the treatment of patients with coronavirus infection. The decision to refuse from the use of the drug was taken due to security problems, writes Reuters.

So, France has cancelled a decree according to which working in hospitals, doctors could prescribe hydroxychloroquine patients, and the Italian and Belgian regulators have suspended the permission to use the drug outside of clinical trials. The Supervisory authorities of Belgium emphasized that ongoing clinical trials will also be appreciated the potential risks of the drug.

In an article published in The Lancet, says that patients treated with hydroxychloroquine, it was observed an increased risk of death and heart rhythm disturbances. European regulators concluded that the identified risks and insufficient evidence of efficacy is not evidence in favor of its use in broad populations of patients with coronavirus.

Leave a Reply

Your email address will not be published. Required fields are marked *

Releated

For the six months Kurgan “Synthesis” increased revenue by 42%

Revenue of JSC “Sintez” (part of the Allium Group) for 6 months of 2020 has increased by 42% year-on-year to 6,767 billion. Net profit reached 752.9 million roubles that on 23% more than in the same period last year. Export sales grew by 36% year-on-year, exceeding 1 billion rubles, told in the company. Secondary sales […]

Russia confirmed on 5 065 new cases COVID-19

In recent days in Russia identified 5 065 new cases of coronavirus in 83 regions. Died 114 people, fully recovered 6 568 patients. In Moscow confirmed 688 new cases of coronavirus. The average rate of increase of new cases for the first two weeks of August is 0.28%. This figure compares with the first two […]